COMPASS patent… compared to proprietary insulin formulations and asthma inhalers created to increase corporate profits… will share similar issues to “big pharma, big tech, big ag [agriculture], and other monopoly-heavy industries.” COMPASS’s attempt to dismiss the dispute against their patent… “Although Patent Owner does not address the substance of Petitioner’s challenge, after considering the arguments…
The London-based firm filed to raise US$100 million, a placeholder amount likely to change, according to a filing Friday [8/28/2020] with the U.S. Securities and Exchange Commission. …has seen a renaissance in recent years in the scientific community. Scientists can’t exactly explain why psychedelics appear to help patients. Emerging brain-scanning technology suggests the substances can…
Researchers of the University of Zurich have now shown that mindfulness meditation can enhance the positive long-term effects of a single dose of psilocybin, which is found in certain mushrooms. “Our findings shed light on the interplay between pharmacological and extra-pharmacological factors in psychedelic states of mind,” says Vollenweider. “They indicate that mindfulness training enhances…
…technique in kilogram-scale synthesis of pharmaceutical grade psilocybin in [an] open-access journal… Making this discovery publicly available is the result of… Open Science [and Praxis] commitment to advance scientific knowledge in the field. The 1.2 kilograms of psilocybin per batch that this process delivers can be used to provide nearly fifty thousand 25-milligram doses of…
After waiting more than three months for a response, Canada’s Minister of Health Patty Hajdu finally granted exemptions to four patients, marking the first legal exemption for psilocybin ( use, outside of a clinical trial, since the substance was deemed illegal in 1974. “We would like to extend our incredible gratitude to the Honorable Minister…
A note about psychedelics and hallucinogens – These terms are often used interchangeably, which can be misleading. Many psychedelics [entheogens and ethnobotanicals] do not cause hallucinations at low doses. Therefore, using the blanket term hallucinogen to describe the effects of all doses of psilocybin [and psilocybin-containing mushrooms/psilocybe mushrooms], for example, is incorrect… Original Article (Psychedelic…
While the FDA can eventually approve the use of GMP psilocybin for one indication or another… …“magic mushrooms”can never be approved (if for no other reason than the concentration of psilocybin and related compounds varies widely in mushroom)… must go through all the regulatory pathways that any other novel chemical entity might have to clear.…
Some participants in studies using pure, synthetic psilocybin report nausea as a side effect of their treatment. This points the finger at [synthetic] psilocybin as a possible cause of nausea… Also, because the body quickly converts psilocybin to its active form psilocin, this suggests that psilocin may play a role in nausea. Original Article (Psychedelic…
A New York lawmaker recently introduced a bill to decriminalize psilocybin… by removing the main active ingredient from the state’s list of controlled substances. “Many cities, including Denver, CO, Santa Cruz, CA, and Oakland, CA, have already decriminalized the use and possession of psilocybin, and New York should do the same,” it continues. “With the…
The London-based biotech is advancing the drug, [one of the many] active ingredient[s] in magic mushrooms … Compass has partnered with academic centers, primarily in the U.S. …is advancing the clinical program while also working on earlier-stage projects. The biotech… focuse[s] on psilocybin therapy in the belief it could leverage existing knowledge of the drug…
